An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]

Código QR

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]

Citrome L, Graham C, Simmons A, et al. Neuropsychiatr Dis Treat. 2021;17:2885–2904. The authors have advised there is an error in Figure 1C on page 2894. The key “OLZ/SAM” should read “Olanzapine + samidorphan 10 mg” and “Olanzapine&rdq...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	antipsychotic agents clinical efficacy olanzapine opioid antagonists safety weight gain Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/2f956761b90540fb83ae4e6a7146f4e3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
por: Citrome L, et al.
Publicado: (2021)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome L, et al.
Publicado: (2019)

Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis
por: Sapunar Z,Jorge, et al.
Publicado: (2009)

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
por: Ward K, et al.
Publicado: (2019)

One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
por: Mohammed Zain Ulabedin Adhoni, et al.
Publicado: (2021)

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Parthasaradhireddy Tanguturi, et al.
Publicado: (2021)

Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis
por: Armita Abolghasemi, et al.
Publicado: (2021)

Can Naloxegol Therapy Improve Quality of Life in Patients with Advanced Cancer?
por: Rita Ostan, et al.
Publicado: (2021)

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
por: Okazaki K, et al.
Publicado: (2017)

Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors
por: De Santis M, et al.
Publicado: (2018)

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
por: Faden J, et al.
Publicado: (2019)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Stephan Hjorth, et al.
Publicado: (2021)

Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients
por: Daoust R, et al.
Publicado: (2020)

Terapia médica de la ginecomastia con tamoxifeno. Influencia del volumen y duración de la ginecomastia en el resultado terapéutico
por: Devoto C,Enzo, et al.
Publicado: (2007)

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
por: Wang G, et al.
Publicado: (2016)

Prevalence and duration of prescribed opioid use during pregnancy: a cohort study from the Quebec Pregnancy Cohort
por: Jin-Ping Zhao, et al.
Publicado: (2021)

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
por: Dayabandara M, et al.
Publicado: (2017)

Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency
por: Joseph V. Pergolizzi, et al.
Publicado: (2021)

Exploring Influences on Theory of Mind Impairment in Opioid Dependent Patients
por: Katharina Eidenmueller, et al.
Publicado: (2021)

Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight
por: Findling RL, et al.
Publicado: (2018)

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
por: Patrycja Redkiewicz, et al.
Publicado: (2021)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Michael Soyka
Publicado: (2021)

Communication between patients and health care professionals about opioid medications
por: Tanvee Thakur, et al.
Publicado: (2021)

Priapismo secundario a antipsicóticos: a propósito de un caso asociado a risperidona
por: Cruzado,Lizardo, et al.
Publicado: (2012)

Hipertensión arterial resistente
por: Feldstein,Carlos A
Publicado: (2008)

The Dual Role of Senescence in Tumorigenesis
por: Chuaire-Noack,Lilian, et al.
Publicado: (2010)

Paracetamol como coadyuvante a opioides fuertes en dolor oncológico moderado a intenso: ¿es realmente efectivo?
por: vLeiva-Vásquez,Ofelia, et al.
Publicado: (2021)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome L, et al.
Publicado: (2021)

Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
por: Chih-Sung Liang, et al.
Publicado: (2021)

Role of Vitamin D in the Development of Obesity
por: Merino,O., et al.
Publicado: (2017)

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
por: Tsuboi T, et al.
Publicado: (2020)

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
por: Yang F, et al.
Publicado: (2018)

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
por: Citrome L
Publicado: (2018)

REGIONAL FEATURES OF BIFIDOBACTERIA ANTAGONISTIC ACTIVITY IN INTESTINAL MICROBIOTA OF CHILDREN LIVING IN SIBERIA
por: E. B. Rakova, et al.
Publicado: (2012)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
por: Kishi T, et al.
Publicado: (2017)

Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder
por: Amanda R. W. Berry, et al.
Publicado: (2021)

The effect of a Life Care Specialist on pain management and opioid-related outcomes among patients with orthopedic trauma: study protocol for a randomized controlled trial
por: Nicholas A. Giordano, et al.
Publicado: (2021)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin N, et al.
Publicado: (2020)

Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
por: Rosenberg R, et al.
Publicado: (2021)

Dexmedetomidine and Clonidine as an Adjuvant to Bupivacaine in Ultrasound Guided Supraclavicular Brachial Plexus Block- A Randomised Clinical Trial
por: Yuvaraj shastri, et al.
Publicado: (2021)